A herbal label can stall late in development, when the formula is fixed, artwork is underway and marketing has already chosen its benefit language. The copy may read well, yet the review still fails because no one checked how the ingredient fits within the food regulatory structure before the claims discussion began.
When a team considers a botanical such as gymnema sylvestre extract, traditional familiarity isn’t enough to settle the label position. The team needs to establish how the material is classified, how the finished product is positioned and whether the proposed language follows from those decisions.
Who Regulates This
FSSAI is India’s food safety regulator, and health supplements and nutraceuticals sit within a dedicated regulatory framework. They aren’t assessed only through the broad assumptions that may apply to ordinary packaged foods, which is why a claims review can’t be left until the final artwork stage.
For a regulatory or formulation manager, the practical question isn’t whether a phrase sounds modest. It is whether the ingredient, product category and presentation support that phrase when read together. A manufacturer may supply a botanical extract to an agreed specification, but the brand still has to establish a defensible link between the selected material and what appears on the pack.
How Ingredients Get Sorted
FSSAI’s regulatory structure separates ingredients into schedules. Nutrients such as vitamins, minerals and amino acids sit apart from plant or botanical materials, while other schedules cover isolates, extracts and molecules, as well as prebiotics and probiotics.
The distinction isn’t merely administrative. FSSAI’s draft norms for nutraceutical ingredients describe plant and botanical materials as a separate category rather than treating every concentrated ingredient as a standard nutrient. That affects the questions a brand should answer before it develops benefit language.
An internal brief should bring together the botanical identity, plant part, supplied form and intended product description. It should also show the wording proposed for the label, website and sales material. Procurement may use a commercial ingredient name, formulation may focus on an active marker, and marketing may lean on traditional use. The regulatory file needs those descriptions to refer to the same material.
See Also: Why Vanilla Pea Protein Powder Has Become a Daily Staple for Health-Conscious People
Botanical Classification
A botanical extract can sound straightforward until the paperwork is compared. A powder, a water extract and a standardised extract may share a plant name while differing in process description, composition and specification. Those differences matter when a team is deciding how to describe the ingredient and what it can reasonably say about the finished product.
Start with the material, not the desired claim. Confirm the botanical name, the plant part, extraction method and agreed specification with the manufacturing partner. Where the extract is standardised, the documentation should state what the standardisation refers to, rather than leaving a broad ingredient name to carry more meaning than it can support.
This is where old labels cause trouble. A competitor’s pack, a previous artwork file or a supplier presentation may show language that looks familiar, but none proves the same formulation, classification or regulatory position applies to a new product. Familiar wording is not evidence for a new label.
The Current Rulebook
FSSAI has proposed reorganising the health supplement and nutraceutical framework through draft updates to earlier regulations. That history is a reason to check the live regulatory material rather than relying on a formulation brief prepared for an earlier product launch.
Before claims copy is approved, review FSSAI’s standards page for health supplements and the material available through it. It is a better starting point than a remembered interpretation or wording copied from an unrelated product.
The aim isn’t to turn every label review into a legal exercise. It is to raise the classification question while the team can still alter the formula, product category or communication plan. A late change can affect packaging, launch material and the documents a manufacturing partner must provide.
Claims Wording
Therapeutic and curative language is a restricted area for health supplement products. Copy should not make a food supplement sound like a diagnosis, treatment or cure, even where the botanical has a long history of use in traditional systems.
Language such as “traditionally used for” or “may support” is generally a more cautious starting register than a promise of an outcome. It still needs review in the setting of the full label. A restrained sentence can take on a different meaning when it sits beside strong imagery, a product name or nearby statements that imply a disease claim.
The review should extend beyond the pack. Product listings, brochures, sales decks and distributor material can change how the intended message is read. Keep the approved claim position aligned across every document that presents the product to a client, partner or regulator.
Before You Finalise a Label
The useful sequence is straightforward. Confirm the ingredient’s FSSAI classification, check the current standards material and then assess whether the proposed wording matches the formula and intended positioning. Copy comes after that work, not before it.
Ask the manufacturing partner for clear botanical identity, process details, test documentation and batch specifications while the formulation is still open to review. Those records do not write a compliant claim by themselves, but they give the internal reviewer the material needed to judge whether the label says only what the product can responsibly support. Request the ingredient documents before approving claims copy or final artwork.



